Delusional misidentification in Parkinson’s disease: report of two cases and a review

References

• Szatmari S, Illigens BM, Siepmann T, et al. Neuropsychiatric symptoms in untreated Parkinson’s disease. Neuropsychiatr Dis Treat. 2017;13:815–826.
   PubMed Web of Science ®Google Scholar
• Balestrino R, Martinez-Martin P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. J Neurol Sci. 2017;373:173–178.
   PubMed Web of Science ®Google Scholar
• Wilby KJ, Johnson EG, Johnson HE, et al. Evidence-based review of pharmacotherapy used for Parkinson’s disease psychosis. Ann Pharmacother. 2017 Apr 1;1060028017703992.
   Web of Science ®Google Scholar
• Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson’s disease: report of an NINDS, NIMH work group. Mov Disord. 2007;22:1061–1068.
   PubMed Web of Science ®Google Scholar
• Goetz CG, Fan W, Leurgans S, et al. The malignant course of “benign hallucinations” in Parkinson disease. Arch Neurol. 2006;63:713–716.
   PubMed Web of Science ®Google Scholar
• Ffytche DH, Pereira JB, Ballard C, et al. Risk factors for early psychosis in PD: insights from the Parkinson’s Progression Markers Initiative. J Neurol Neurosurg Psychiatry. 2017;88(4):325–331.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21:629–634.
   PubMed Web of Science ®Google Scholar
• Factor SA, Molho ES. Emergency department presentations of patients with Parkinson’s disease. Am J Emerg Med. 2000;18:209–215.
   PubMed Web of Science ®Google Scholar
• Klein C, Prokhorov T, Miniovitz A, et al. Admission of Parkinsonian patients to a neurological ward in a community hospital. J Neural Transm. 2009;116:1509–1512.
   PubMed Web of Science ®Google Scholar
• Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson’s disease. Neurology. 1993;43:2227–2229.
   PubMed Web of Science ®Google Scholar
• Joseph AB. Observations on the epidemiology of the delusional misidentification syndromes in the Boston metropolitan area: April 1983–June 1984. Psychopathology. 1994;27:150–153.
   PubMed Web of Science ®Google Scholar
• Perini G, Carlini A, Pomati S, et al. Misidentification delusions: prevalence in different types of dementia and validation of a structured questionnaire. Alzheimer Dis Assoc Disord. 2016;30:331–337.
   PubMed Web of Science ®Google Scholar
• Moro A, Munhoz RP, Moscovich M, et al. Delusional misidentification syndrome and other unusual delusions in advanced Parkinson’s disease. Parkinsonism Relat Disord. 2013;19:751–754.
   PubMed Web of Science ®Google Scholar
• Cannas A, Meloni M, Mascia MM, et al. Capgras syndrome in Parkinson’s disease: two new cases and literature review. Neurol Sci. 2017;38:225–231.
   PubMed Web of Science ®Google Scholar
• Pagonabarraga J, Llebaria G, García-Sánchez C, et al. A prospective study of delusional misidentification syndromes in Parkinson’s disease with dementia. Mov Disord. 2008;23:443–448.
   PubMed Web of Science ®Google Scholar
• Kapur N, Turner A, King C. Reduplicative paramnesia: possible anatomical and neuropsychological mechanisms. J Neurol Neurosurg Psychiatry. 1988;51:579–581.
   PubMed Web of Science ®Google Scholar
• Islam L, Piacentini S, Soliveri P, et al. Capgras delusion for animals and inanimate objects in Parkinson’s disease: a case report. BMC Psychiatry. 2015;15:73.
   PubMed Web of Science ®Google Scholar
• Josephs KA. Capgras syndrome and its relationship to neurodegenerative disease. Arch Neurol. 2007;64:1762–1766.
   PubMedGoogle Scholar
• Groth C, Pusso A, Huss D, et al. Capgras syndrome in advanced Parkinson’s disease. International Congress of Parkinson's Disease and Movement Disorders, June 4-8, 2017, Vancouver, BC, Canada. Poster 1072; 2017. p. 704.
   Google Scholar
• Ray S, Park D, Burdick D, et al. Delusional misidentification for “self” in two patients with Parkinson’s disease. International Congress of Parkinson's Disease and Movement Disorders, June 4-8, 2017, Vancouver, BC, Canada. Poster 1095; 2017. p. 723.
   Google Scholar
• Stewart JT. Frégoli syndrome associated with levodopa treatment. Mov Disord. 2008;23:308–309.
   PubMed Web of Science ®Google Scholar
• Politis M, Loane C. Reduplicative paramnesia: a review. Psychopathology. 2012;45:337–343.
   PubMed Web of Science ®Google Scholar
• Langdon R, Coltheart M. The cognitive neuropsychology of delusions. Mind Lang. 2000;15:184–218.
   Web of Science ®Google Scholar
• Thiel CM, Studte S, Hildebrandt H, et al. When a loved one feels unfamiliar: a case study on the neural basis of Capgras delusion. Cortex. 2014;52:75–85.
   PubMed Web of Science ®Google Scholar
• Darby RR, Laganiere S, Pascual-Leone A, et al. Finding the imposter: brain connectivity of lesions causing delusional misidentifications. Brain. 2017;140(2):497–507.
   PubMed Web of Science ®Google Scholar
• Ellis HD, Young AW, Quayle AH, et al. Reduced autonomic responses to faces in Capgras delusion. Proc Biol Sci. 1997;264:1085–1092.
   PubMed Web of Science ®Google Scholar
• Graff-Radford J, Ahlskog JE, Bower JH, et al. Dopamine agonists and Othello’s syndrome. Parkinsonism Relat Disord. 2010;16:680–682.
   PubMed Web of Science ®Google Scholar
• Nagy H, Levy-Gigi E, Somlai Z, et al. The effect of dopamine agonists on adaptive and aberrant salience in Parkinson’s disease. Neuropsychopharmacology. 2012;37:950–958.
   PubMed Web of Science ®Google Scholar
• Mohr E, Mendis T, Hildebrand K, et al. Risperidone in the treatment of dopamine-induced psychosis in Parkinson’s disease: an open pilot trial. Mov Disord. 2000;15:1230–1237.
   PubMed Web of Science ®Google Scholar
• Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014;383:533–540.
   PubMed Web of Science ®Google Scholar
• Hacksell U, Burstein ES, McFarland K, et al. On the discovery and development of pimavanserin: a novel drug candidate for Parkinson’s psychosis. Neurochem Res. 2014;39:2008–2017.
   PubMed Web of Science ®Google Scholar
• Kaufman KR, Newman NB, Dawood A. Capgras delusion with violent behavior in Alzheimer dementia: case analysis with literature review. Ann Clin Psychiatry. 2014;26:187–191.
   PubMed Web of Science ®Google Scholar
• Shiotsuki H, Motoi Y, Nakamura S, et al. Dopamine deficiency may lead to Capgras syndrome in Parkinson’s disease with dementia. J Neuropsychiatry Clin Neurosci. 2010;22:352.e14–352.e15.
   PubMed Web of Science ®Google Scholar
• Slotnik D. Tony Rosato, of 1981–82 ‘Saturday Night Live’ cast, dies at 62. New York Times (New York (NY)). 2017 Jan 16. p. B6.
   Google Scholar